2015


165. Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following         Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa. Nzenze SA, von Gottberg A,        Shiri T, van Niekerk N, de Gouveia L, Violari A, Nunes MC, Madhi SA. J Infect Dis. 2015 Oct 1;212(7):1082-92. Doi:        10.1093/infdis/jiv167. Epub 2015 Mar 17. PMID: 25784729 Impact Factor: 5.9


166. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition         in pregnant women. Kwatra G, Adrian PV, Shiri T, Buchmann EJ, Cutland CL, Madhi SA. Clin Microbiol Infect. 2015         Jun;21(6):568.e13-21. doi: 10.1016/j.cmi.2015.01.030. Epub 2015 Feb 10. PMID: 25680313 Impact Factor: 5.1


167. HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced        Transplacental Antibody Transfer in Pregnant Women. Dangor Z, Kwatra G, Izu A, Adrian P, van Niekerk N, Cutland CL, Adam        Y, Velaphi S, Lala SG, Madhi SA. J Infect Dis. 2015 Aug 1;212(3):453-62. doi: 10.1093/infdis/jiv064. Epub 2015 Feb 4.

       PMID: 25651843 Impact Factor: 5.9


168. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and        their infants: a randomised phase 1b/2 trial. Madhi SA, Cutland CL, Jose L, Koen A, Govender N, Wittke F, Olugbosi M,        Meulen AS, Baker S, Dull PM, Narasimhan V, Slobod K.

       Lancet Infect Dis. 2016 Apr 29. pii: S1473-3099(16)00152-3. doi: 10.1016/S1473-3099(16)00152-3. [Epub ahead of print]

       PMID: 27139805 Impact Factor: 9.26


169. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus        Vaccine in South African Infants. Moon SS, Groome MJ, Velasquez DE, Parashar UD, Jones S, Koen A, van Niekerk N, Jiang B,        Madhi SA. Clin Infect Dis. 2016 Jan 15;62(2):157-65. doi: 10.1093/cid/civ828. Epub 2015 Sep 23. PMID: 26400993 Impact Factor:        8.88


170. Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected        South African children: a case-control study. Madhi SA, Groome MJ, Zar HJ, Kapongo CN, Mulligan C, Nzenze S, Moore DP,        Zell ER, Whitney CG, Verani JR. Thorax. 2015 Dec;70(12):1149-55. doi: 10.1136/thoraxjnl-2014-206593. Epub 2015 Jun 19.

       PMID: 26092924 Impact Factor: 8.29


180. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those         Without HIV Infection and Their Infants. Nunes MC, Cutland CL, Dighero B, Bate J, Jones S, Hugo A, van Niekerk N, Kuwanda         L, Izu A, Weinberg A, Madhi SA; Matflu Team. J Infect Dis. 2015 Dec 15;212(12):1976-87. doi: 10.1093/infdis/jiv339. Epub 2015         Jun 16. PMID: 26080370 Impact Factor 5.9


181. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).

       Cutland CL, Schrag SJ, Thigpen MC, Velaphi SC, Wadula J, Adrian PV, Kuwanda L, Groome MJ, Buchmann E, Madhi SA.

       Emerg Infect Dis. 2015 Apr;21(4):638-45. doi: 10.3201/eid2104.141562. PMID: 25812061 Impact Factor: 6.75


182. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time         series analysis. Nanoo A, Izu A, Ismail NA, Ihekweazu C, Abubakar I, Mametja D, Madhi SA. Lancet Infect Dis. 2015         Sep;15(9):1066-76. doi: 10.1016/S1473-3099(15)00147-4. Epub 2015 Jun 22. PMID: 26112077 Impact Factor: 9.26


183. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to        pneumococcal vaccination. Bhorat AE, Madhi SA, Laudat F, Sundaraiyer V, Gurtman A, Jansen KU, Scott DA, Emini EA,        Gruber WC, Schmoele-Thoma B. AIDS. 2015 Jul 17;29(11):1345-54. doi: 10.1097/QAD.0000000000000689. PMID: 25888646 Impact        Factor: 5.55


184. Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area,        South Africa, 1998-2009(1).  Tempia S, Walaza S, Viboud C, Cohen AL, Madhi SA, Venter M, von Mollendorf C, Moyes J,        McAnerney JM, Cohen C.Emerg Infect Dis. 2015 Apr;21(4):600-8. doi: 10.3201/eid2104.141033.

       PMID: 25811455  Impact Factor: 6.75



185. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics.

        Mazur NI, Martinón-Torres F, Baraldi E, Fauroux B, Greenough A, Heikkinen T, Manzoni P, Mejias A, Nair H, Papadopoulos         NG, Polack FP, Ramilo O, Sharland M, Stein R, Madhi SA, Bont L; Respiratory Syncytial Virus Network (ReSViNET).

        Lancet Respir Med. 2015 Nov;3(11):888-900. doi: 10.1016/S2213-2600(15)00255-6. Epub 2015 Sep 25. Review.

        PMID: 26411809 Impact Factor: 9.6


186. Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. von Mollendorf C, Cohen C, Tempia S,         Meiring S, de Gouveia L, Quan V, Lengana S, Karstaedt A, Dawood H, Seetharam S, Lekalakala R, Madhi SA, Klugman KP,         von Gottberg A; Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa (GERMS-SA).

        Emerg Infect Dis. 2016 Feb;22(2):261-70. doi: 10.3201/eid2202.150967. PMID: 26812214 Impact Factor 6.75


187. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label,        multicentre trial. Heyderman RS, Madhi SA, French N, Cutland C, Ngwira B, Kayambo D, Mboizi R, Koen A, Jose L, Olugbosi        M, Wittke F, Slobod K, Dull PM. Lancet Infect Dis. 2016 Feb 8. pii: S1473-3099(15)00484-3. doi: 10.1016/S1473-3099(15)00484-3.        [Epub ahead of print]PMID: 26869376 Impact Factor: 9.26


188. Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology. Quan V, Verani JR, Cohen        C, von Gottberg A, Meiring S, Cutland CL, Schrag SJ, Madhi SA. PLoS One. 2016 Apr 7;11(4):e0152524. Doi:        10.1371/journal.pone.0152524. eCollection 2016. PMID: 27055184 Impact Factor: 3.23



189. Serotype-Specific Cell-Mediated Immunity Associated With Clearance of Homotypic Group B Streptococcus Rectovaginal        Colonization in Pregnant Women. Kwatra G, Adrian PV, Shiri T, Izu A, Cutland CL, Buchmann EJ, Madhi SA. J Infect Dis. 2016        Mar 29. pii: jiw056. [Epub ahead of print] PMID: 27029777 Impact Factor: 2.7


190. Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants.

        Cohen C, Moyes J, Tempia S, Groome M, Walaza S, Pretorius M, Naby F, Mekgoe O, Kahn K, von Gottberg A, Wolter N, Cohen         AL, von Mollendorf C, Venter M, Madhi SA. Pediatrics. 2016 Mar 29. pii: e20153272. [Epub ahead of print] PMID: 27025960         Impact Factor: 2.7


191. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African        infants. Dangor Z, Kwatra G, Izu A, Adrian P, Cutland CL, Velaphi S, Ballot D, Reubenson G, Zell ER, Lala SG, Madhi SA.

       Vaccine. 2015 Nov 27;33(48):6793-9. doi: 10.1016/j.vaccine.2015.10.019. Epub 2015 Oct 23. PMID: 26478200 Impact Factor: 3.6


192. Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-         middle income country. Cutland CL, Cunnington M, Olugbosi M, Jones SA, Hugo A, Maharaj K, Slobod K, Madhi SA.

        Vaccine. 2015 Nov 25;33(47):6406-12. doi: 10.1016/j.vaccine.2015.08.040. Epub 2015 Sep 26. PMID: 26409812 Impact Factor: 3.6


193. Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their        infants. Dangor Z, Kwatra G, Izu A, Adrian P, Cutland CL, Velaphi S, Ballot D, Reubenson G, Zell ER, Lala SG, Madhi SA.

       Expert Rev Vaccines. 2015;14(12):1651-60. doi: 10.1586/14760584.2015.1085307. Epub 2015 Sep 12. Impact Factor: 4.2


194. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South        African experience. Madhi SA, Nunes MC. Hum Vaccin Immunother. 2016 Feb;12(2):314-25. doi: 10.1080/21645515.2015.1084450.

       PMID: 26317537


195. Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries.

        White A, Madhi SA. Vaccine. 2015 Nov 25;33(47):6396-400. doi: 10.1016/j.vaccine.2015.07.108. Epub 2015 Aug 11.

        PMID: 26271832 Impact Factor: 3.6


196. Review on the effects of influenza vaccination during pregnancy on preterm births. Nunes MC, Madhi SA. Hum Vaccin         Immunother. 2015;11(11):2538-48. doi: 10.1080/21645515.2015.1059976. Epub 2015 Aug 12. PMID: 26267701


197. Human metapneumovirus-associated severe acute respiratory illness hospitalisation in HIV-infected and HIV-uninfected         South African children and adults.  Groome MJ, Moyes J, Cohen C, Walaza S, Tempia S, Pretorius M, Hellferscee O, Chhagan         M, Haffejee S, Dawood H, Kahn K, Variava E, Cohen AL, Gottberg Av, Wolter N, Venter M, Madhi SA; South African Severe         Acute Respiratory Illness (SARI) Surveillance Group. J Clin Virol. 2015 Aug;69:125-32. doi: 10.1016/j.jcv.2015.06.089. Epub 2015         Jun 18. PMID: 26209394 Impact Factor: 3.0


198. Bacterial and Respiratory Viral Interactions in the Etiology of Acute Otitis Media in HIV-infected and HIV-uninfected South         African Children.  Madhi SA, Govender N, Dayal K, Devadiga R, Van Dyke MK, van Niekerk N, Cutland CL, Adrian PV, Nunes         MC. Pediatr Infect Dis J. 2015 Jul;34(7):753-60. doi: 10.1097/INF.0000000000000733.PMID: 25923426 Impact Factor: 2.6


199. Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal        colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine. Madhi SA, Izu A,        Nunes MC, Violari A, Cotton MF, Jean-Philippe P, Klugman KP, von Gottberg A, van Niekerk N, Adrian PV;CIPRA 4 team.        Vaccine. 2015 May 28;33(23):2662-9. doi: 10.1016/j.vaccine.2015.04.024. Epub 2015 Apr 21.

       PMID: 25910923 Impact Factor: 3.6


200. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.

       Dangor Z, Lala SG, Cutland CL, Koen A, Jose L, Nakwa F, Ramdin T, Fredericks J, Wadula J, Madhi SA. PLoS One. 2015 Apr        7;10(4):e0123014. doi: 10.1371/journal.pone.0123014. eCollection 2015. PMID: 25849416 Impact Factor: 3.23


201. WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting        held on 23-24 March 2015. Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS; WHO RSV Vaccine Consultation Expert        Group. Vaccine. 2016 Jan 4;34(2):190-7. doi: 10.1016/j.vaccine.2015.05.093. Epub 2015 Jun 20.

       PMID: 26100926 Impact Factor: 3.6


202. Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: Methods and expectations.

       Omer SB, Richards JL, Madhi SA, Tapia MD, Steinhoff MC, Aqil AR, Wairagkar N; BMGF Supported Maternal Influenza        Immunization Trials Investigators Group. Vaccine. 2015 Jul 31;33(32):3801-12. doi: 10.1016/j.vaccine.2015.05.077. Epub 2015 Jun        19. Review. PMID: 26095508 Impact Factor: 3.6


203. Maternal group B Streptococcus-related stillbirth: a systematic review. Nan C, Dangor Z, Cutland CL, Edwards MS, Madhi SA,        Cunnington MC. BJOG. 2015 Oct;122(11):1437-45. doi: 10.1111/1471-0528.13527. Epub 2015 Jul 14. Review.

       PMID: 26177561 Impact Factor: 3.7



204. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years:         Systematic review and meta-analysis. Shi T, Balsells E, Wastnedge E, Singleton R, Rasmussen ZA, Zar HJ, Rath BA, Madhi SA,         Campbell S, Vaccari LC, Bulkow LR, Thomas ED, Barnett W, Hoppe C, Campbell H, Nair H. J Glob Health. 2015         Dec;5(2):020416. doi: 10.7189/jogh.05.020416. PMID: 26682048


205. Parainfluenza Virus Infection Among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Children and Adults        Hospitalized for Severe Acute Respiratory Illness in South Africa, 2009-2014. Cohen AL, Sahr PK, Treurnicht F, Walaza S,        Groome MJ, Kahn K, Dawood H, Variava E, Tempia S, Pretorius M, Moyes J, Olorunju SA, Malope-Kgokong B, Kuonza L, Wolter        N, von Gottberg A, Madhi SA, Venter M, Cohen c. Open Forum Infect Dis. 2015 Sep 19;2(4):ofv139. doi: 10.1093/ofid/ofv139.        eCollection 2015 Dec. PMID: 26566534



206. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain        reaction-based surveillance: an experience from South Africa. Tempia S, Wolter N, Cohen C, Walaza S, von Mollendorf C,        Cohen AL, Moyes J, de Gouveia L, Nzenze S, Treurnicht F, Venter M, Groome MJ, Madhi SA, von Gottberg A. BMC Infect Dis.        2015 Oct 26;15:450. doi: 10.1186/s12879-015-1198-z. PMID: 26496761 Impact factor: 2.61


207. Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National        Surveillance Data, 2003 - 2008. Cohen C, Naidoo N, Meiring S, de Gouveia L, von Mollendorf C, Walaza S, Naicker P, Madhi        SA, Feldman C, Klugman KP, Dawood H, von Gottberg A; GERMS-SA. PLoS One. 2015 Oct 13;10(10):e0140185. Doi:        10.1371/journal.pone.0140185. eCollection 2015. PMID: 26460800 Impact Factor: 3.23


208. The bronchiolitis season is upon us--recommendations for the management and prevention of acute viral bronchiolitis.

       Zar HJ, White DA, Morrow B, Feldman C, Risenga S, Masekela R, Lewis H, Jeena P, Madhi SA. S Afr Med J. 2015 Sep        21;105(7):525-6. doi: 10.7196/SAMJnew.8040. PMID: 26428741 Impact Factor: 2.7


209. Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country         observational study. Rivera L, Sáez-Llorens X, Feris-Iglesias J, Ip M, Saha S, Adrian PV, Madhi SA, Boudville IC, Cunnington          MC, Casellas JM, Slobod KS. BMC Pediatr. 2015 Oct 1;15:143. doi: 10.1186/s12887-015-0460-2. PMID: 26427955 Impact Factor 1.9



210 Sapovirus prevalence in children less than five years of age hospitalised for diarrhoeal disease in South Africa, 2009-2013.

      Page N, Groome MJ, Murray T, Nadan S, Netshikweta R, Keddy KH, Poonsamy B, Moyes J, Walaza S, Kahn K, Kuonza L, Taylor       MB, Madhi SA, Cohen c. J Clin Virol. 2016 May;78:82-8. doi: 10.1016/j.jcv.2016.03.013. Epub 2016 Mar 19. PMID: 27002709 Impact       Factor: 3.0



211. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior     to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). Meiring S, Cohen C, Quan V, de Gouveia L, Feldman C,     Karstaedt A, Klugman KP, Madhi SA, Rabie H, Sriruttan C, von Gottberg A; GERMS-SA. PLoS One. 2016 Feb 10;11(2):e0149104. Doi:     10.1371/journal.pone.0149104. eCollection 2016. PMID: 26863135 Impact Factor: 3.23


212. Knowledge, attitudes, and practices about influenza illness and vaccination: A cross-sectional survey in two South African         communities. Wong KK, Cohen AL, Norris SA, Martinson NA, von Mollendorf C, Tempia S, Walaza S, Madhi SA, McMorrow ML,          Variava E, Motlhaoleng KM, Cohen c. Influenza Other Respir Viruses. 2016 Mar 14. doi: 10.1111/irv.12388. [Epub ahead of          print] PMID: 26987756





VPD/RMPRU

11th Floor Central West Wing

Nurses Residence

Chris Hani Baragwanath Hospital

Diepkloof, Soweto

Phone: 011 983 4260

Fax: 086 646 4208

E-mail: siwei@rmpru.co.za

<<<<<<Back to Publications